Dudes, Ipi (Yervoy) US sales up 3% quarter over quarter!!! Looks like we have already topped out on the greatest drug in pharma history!!!
That is the problem with NICHE oncology drugs. When you are one of the only treatments out there, you saturate the market quickly and have no growth potential. Sprycel is the only drug we have that will grow at a solid pace. Outside of that Oncology is cooked. No wonder layoffs are coming this fall. Good luck to you all.